Table 2.
Two-year overall survival (OS) rates of AXLLow and AXLHigh tumors in NSCLC metastasis and NSCLC BM groups
NSCLC metastases | NSCLC brain metastases | |
---|---|---|
Median OS (months) | ||
Low AXL (mo) | 35 | 48 |
High AXL (mo) | 24 | 21 |
2-year survival rates | ||
Low AXL (%) | 65.1 | 68.8 |
High AXL (%) | 48.3 | 44.8 |